TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model.
Castro Eiro MD, Hioki K, Li L, Wilmsen MEP, Kiernan CH, Brouwers-Haspels I, van Meurs M, Zhao M, de Wit H, Grashof DGB, van de Werken HJG, Mueller YM, Schliehe C, Temizoz B, Kobiyama K, Ishii KJ, Katsikis PD.
Castro Eiro MD, et al. Among authors: van meurs m.
J Immunol. 2024 Feb 1;212(3):455-465. doi: 10.4049/jimmunol.2300038.
J Immunol. 2024.
PMID: 38063488
Free PMC article.